nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—NR1I2—Erlotinib—pancreatic cancer	0.19	0.222	CbGbCtD
Rilpivirine—NR1I2—Docetaxel—pancreatic cancer	0.126	0.147	CbGbCtD
Rilpivirine—SLCO1B3—Docetaxel—pancreatic cancer	0.0494	0.0575	CbGbCtD
Rilpivirine—ABCG2—Tamoxifen—pancreatic cancer	0.0406	0.0473	CbGbCtD
Rilpivirine—SLCO1B1—Irinotecan—pancreatic cancer	0.0392	0.0457	CbGbCtD
Rilpivirine—ABCG2—Erlotinib—pancreatic cancer	0.0345	0.0402	CbGbCtD
Rilpivirine—ABCG2—Irinotecan—pancreatic cancer	0.0312	0.0363	CbGbCtD
Rilpivirine—ABCG2—Fluorouracil—pancreatic cancer	0.0299	0.0348	CbGbCtD
Rilpivirine—CYP2B6—Tamoxifen—pancreatic cancer	0.0286	0.0333	CbGbCtD
Rilpivirine—ABCG2—Docetaxel—pancreatic cancer	0.0228	0.0266	CbGbCtD
Rilpivirine—ABCG2—Sunitinib—pancreatic cancer	0.0227	0.0265	CbGbCtD
Rilpivirine—CYP2B6—Irinotecan—pancreatic cancer	0.0219	0.0255	CbGbCtD
Rilpivirine—CYP1A2—Dacarbazine—pancreatic cancer	0.021	0.0245	CbGbCtD
Rilpivirine—CYP2C19—Tamoxifen—pancreatic cancer	0.0181	0.0211	CbGbCtD
Rilpivirine—ABCG2—Doxorubicin—pancreatic cancer	0.017	0.0198	CbGbCtD
Rilpivirine—CYP1A2—Tamoxifen—pancreatic cancer	0.0167	0.0195	CbGbCtD
Rilpivirine—ABCB1—Tamoxifen—pancreatic cancer	0.0146	0.017	CbGbCtD
Rilpivirine—CYP1A2—Erlotinib—pancreatic cancer	0.0142	0.0166	CbGbCtD
Rilpivirine—ABCB1—Gemcitabine—pancreatic cancer	0.0126	0.0147	CbGbCtD
Rilpivirine—ABCB1—Erlotinib—pancreatic cancer	0.0124	0.0145	CbGbCtD
Rilpivirine—CYP1A2—Fluorouracil—pancreatic cancer	0.0123	0.0144	CbGbCtD
Rilpivirine—CYP2B6—Doxorubicin—pancreatic cancer	0.012	0.0139	CbGbCtD
Rilpivirine—ABCB1—Irinotecan—pancreatic cancer	0.0112	0.0131	CbGbCtD
Rilpivirine—CYP3A4—Tamoxifen—pancreatic cancer	0.00877	0.0102	CbGbCtD
Rilpivirine—ABCB1—Docetaxel—pancreatic cancer	0.00824	0.00959	CbGbCtD
Rilpivirine—ABCB1—Sunitinib—pancreatic cancer	0.0082	0.00955	CbGbCtD
Rilpivirine—CYP3A4—Erlotinib—pancreatic cancer	0.00746	0.00869	CbGbCtD
Rilpivirine—CYP3A4—Irinotecan—pancreatic cancer	0.00674	0.00784	CbGbCtD
Rilpivirine—ABCB1—Doxorubicin—pancreatic cancer	0.00614	0.00715	CbGbCtD
Rilpivirine—CYP3A4—Docetaxel—pancreatic cancer	0.00494	0.00575	CbGbCtD
Rilpivirine—CYP3A4—Sunitinib—pancreatic cancer	0.00491	0.00572	CbGbCtD
Rilpivirine—CYP3A4—Doxorubicin—pancreatic cancer	0.00368	0.00428	CbGbCtD
Rilpivirine—Pazopanib—KDR—pancreatic cancer	0.00365	1	CrCbGaD
Rilpivirine—Blood creatinine increased—Tamoxifen—pancreatic cancer	0.000815	0.00605	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Tamoxifen—pancreatic cancer	0.000783	0.00581	CcSEcCtD
Rilpivirine—Renal impairment—Sunitinib—pancreatic cancer	0.000782	0.00581	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Tamoxifen—pancreatic cancer	0.000767	0.00569	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Erlotinib—pancreatic cancer	0.000759	0.00563	CcSEcCtD
Rilpivirine—Hepatotoxicity—Docetaxel—pancreatic cancer	0.000756	0.00562	CcSEcCtD
Rilpivirine—Abdominal discomfort—Tamoxifen—pancreatic cancer	0.00072	0.00535	CcSEcCtD
Rilpivirine—Blood creatinine increased—Sunitinib—pancreatic cancer	0.000698	0.00518	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Sunitinib—pancreatic cancer	0.000671	0.00498	CcSEcCtD
Rilpivirine—Depression—Tamoxifen—pancreatic cancer	0.000668	0.00496	CcSEcCtD
Rilpivirine—Depression—Erlotinib—pancreatic cancer	0.000661	0.00491	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Sunitinib—pancreatic cancer	0.000657	0.00488	CcSEcCtD
Rilpivirine—Renal failure—Erlotinib—pancreatic cancer	0.000652	0.00484	CcSEcCtD
Rilpivirine—Transaminases increased—Epirubicin—pancreatic cancer	0.000648	0.00481	CcSEcCtD
Rilpivirine—Renal impairment—Irinotecan—pancreatic cancer	0.000645	0.00478	CcSEcCtD
Rilpivirine—Serum creatinine increased—Epirubicin—pancreatic cancer	0.000641	0.00475	CcSEcCtD
Rilpivirine—Renal impairment—Gemcitabine—pancreatic cancer	0.000628	0.00466	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Erlotinib—pancreatic cancer	0.000627	0.00465	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Docetaxel—pancreatic cancer	0.000618	0.00458	CcSEcCtD
Rilpivirine—Abdominal discomfort—Sunitinib—pancreatic cancer	0.000617	0.00458	CcSEcCtD
Rilpivirine—Inflammation—Docetaxel—pancreatic cancer	0.000602	0.00447	CcSEcCtD
Rilpivirine—Transaminases increased—Doxorubicin—pancreatic cancer	0.000599	0.00445	CcSEcCtD
Rilpivirine—Serum creatinine increased—Doxorubicin—pancreatic cancer	0.000593	0.0044	CcSEcCtD
Rilpivirine—Urinary tract disorder—Erlotinib—pancreatic cancer	0.000588	0.00436	CcSEcCtD
Rilpivirine—Urethral disorder—Erlotinib—pancreatic cancer	0.000583	0.00433	CcSEcCtD
Rilpivirine—Blood creatinine increased—Irinotecan—pancreatic cancer	0.000575	0.00427	CcSEcCtD
Rilpivirine—Depression—Sunitinib—pancreatic cancer	0.000572	0.00425	CcSEcCtD
Rilpivirine—Renal failure—Sunitinib—pancreatic cancer	0.000564	0.00419	CcSEcCtD
Rilpivirine—Blood creatinine increased—Gemcitabine—pancreatic cancer	0.00056	0.00416	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Irinotecan—pancreatic cancer	0.000552	0.0041	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Sunitinib—pancreatic cancer	0.000543	0.00403	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Gemcitabine—pancreatic cancer	0.000538	0.00399	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Gemcitabine—pancreatic cancer	0.000527	0.00391	CcSEcCtD
Rilpivirine—Mental disorder—Erlotinib—pancreatic cancer	0.000521	0.00387	CcSEcCtD
Rilpivirine—Malnutrition—Erlotinib—pancreatic cancer	0.000518	0.00385	CcSEcCtD
Rilpivirine—Urinary tract disorder—Sunitinib—pancreatic cancer	0.000509	0.00378	CcSEcCtD
Rilpivirine—Urethral disorder—Sunitinib—pancreatic cancer	0.000505	0.00375	CcSEcCtD
Rilpivirine—Immune system disorder—Sunitinib—pancreatic cancer	0.000465	0.00345	CcSEcCtD
Rilpivirine—Renal failure—Irinotecan—pancreatic cancer	0.000465	0.00345	CcSEcCtD
Rilpivirine—Renal failure—Gemcitabine—pancreatic cancer	0.000453	0.00336	CcSEcCtD
Rilpivirine—Mental disorder—Sunitinib—pancreatic cancer	0.000451	0.00335	CcSEcCtD
Rilpivirine—Malnutrition—Sunitinib—pancreatic cancer	0.000448	0.00333	CcSEcCtD
Rilpivirine—Renal impairment—Docetaxel—pancreatic cancer	0.000446	0.00331	CcSEcCtD
Rilpivirine—Anxiety—Tamoxifen—pancreatic cancer	0.000444	0.0033	CcSEcCtD
Rilpivirine—Anxiety—Erlotinib—pancreatic cancer	0.00044	0.00326	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000438	0.00325	CcSEcCtD
Rilpivirine—Dry mouth—Tamoxifen—pancreatic cancer	0.000436	0.00324	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Gemcitabine—pancreatic cancer	0.000435	0.00323	CcSEcCtD
Rilpivirine—Infection—Tamoxifen—pancreatic cancer	0.000425	0.00315	CcSEcCtD
Rilpivirine—Infection—Erlotinib—pancreatic cancer	0.00042	0.00312	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Epirubicin—pancreatic cancer	0.000417	0.00309	CcSEcCtD
Rilpivirine—Nervous system disorder—Erlotinib—pancreatic cancer	0.000415	0.00308	CcSEcCtD
Rilpivirine—Creatinine increased—Epirubicin—pancreatic cancer	0.000414	0.00307	CcSEcCtD
Rilpivirine—Skin disorder—Erlotinib—pancreatic cancer	0.000411	0.00305	CcSEcCtD
Rilpivirine—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.000408	0.00303	CcSEcCtD
Rilpivirine—Inflammation—Epirubicin—pancreatic cancer	0.000406	0.00302	CcSEcCtD
Rilpivirine—Urethral disorder—Gemcitabine—pancreatic cancer	0.000405	0.00301	CcSEcCtD
Rilpivirine—Abnormal dreams—Epirubicin—pancreatic cancer	0.000389	0.00289	CcSEcCtD
Rilpivirine—Insomnia—Tamoxifen—pancreatic cancer	0.000386	0.00287	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Doxorubicin—pancreatic cancer	0.000385	0.00286	CcSEcCtD
Rilpivirine—Immune system disorder—Irinotecan—pancreatic cancer	0.000383	0.00285	CcSEcCtD
Rilpivirine—Creatinine increased—Doxorubicin—pancreatic cancer	0.000383	0.00284	CcSEcCtD
Rilpivirine—Insomnia—Erlotinib—pancreatic cancer	0.000382	0.00284	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Docetaxel—pancreatic cancer	0.000382	0.00283	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000379	0.00281	CcSEcCtD
Rilpivirine—Inflammation—Doxorubicin—pancreatic cancer	0.000376	0.00279	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.000374	0.00278	CcSEcCtD
Rilpivirine—Dry mouth—Sunitinib—pancreatic cancer	0.000373	0.00277	CcSEcCtD
Rilpivirine—Immune system disorder—Gemcitabine—pancreatic cancer	0.000373	0.00277	CcSEcCtD
Rilpivirine—Decreased appetite—Tamoxifen—pancreatic cancer	0.000371	0.00276	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000369	0.00274	CcSEcCtD
Rilpivirine—Fatigue—Tamoxifen—pancreatic cancer	0.000368	0.00273	CcSEcCtD
Rilpivirine—Decreased appetite—Erlotinib—pancreatic cancer	0.000368	0.00273	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000365	0.00271	CcSEcCtD
Rilpivirine—Fatigue—Erlotinib—pancreatic cancer	0.000365	0.00271	CcSEcCtD
Rilpivirine—Infection—Sunitinib—pancreatic cancer	0.000364	0.0027	CcSEcCtD
Rilpivirine—Abnormal dreams—Doxorubicin—pancreatic cancer	0.00036	0.00267	CcSEcCtD
Rilpivirine—Nervous system disorder—Sunitinib—pancreatic cancer	0.000359	0.00266	CcSEcCtD
Rilpivirine—Skin disorder—Sunitinib—pancreatic cancer	0.000355	0.00264	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000349	0.00259	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000346	0.00257	CcSEcCtD
Rilpivirine—Abdominal pain—Tamoxifen—pancreatic cancer	0.000338	0.00251	CcSEcCtD
Rilpivirine—Abdominal pain—Erlotinib—pancreatic cancer	0.000334	0.00248	CcSEcCtD
Rilpivirine—Insomnia—Sunitinib—pancreatic cancer	0.000331	0.00246	CcSEcCtD
Rilpivirine—Renal failure—Docetaxel—pancreatic cancer	0.000321	0.00238	CcSEcCtD
Rilpivirine—Decreased appetite—Sunitinib—pancreatic cancer	0.000318	0.00236	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000316	0.00235	CcSEcCtD
Rilpivirine—Fatigue—Sunitinib—pancreatic cancer	0.000316	0.00234	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000309	0.00229	CcSEcCtD
Rilpivirine—Asthenia—Tamoxifen—pancreatic cancer	0.000307	0.00228	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000304	0.00226	CcSEcCtD
Rilpivirine—Asthenia—Erlotinib—pancreatic cancer	0.000303	0.00225	CcSEcCtD
Rilpivirine—Renal impairment—Epirubicin—pancreatic cancer	0.000301	0.00223	CcSEcCtD
Rilpivirine—Infection—Irinotecan—pancreatic cancer	0.0003	0.00222	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000299	0.00222	CcSEcCtD
Rilpivirine—Nervous system disorder—Irinotecan—pancreatic cancer	0.000296	0.00219	CcSEcCtD
Rilpivirine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000292	0.00217	CcSEcCtD
Rilpivirine—Infection—Gemcitabine—pancreatic cancer	0.000292	0.00217	CcSEcCtD
Rilpivirine—Urinary tract disorder—Docetaxel—pancreatic cancer	0.00029	0.00215	CcSEcCtD
Rilpivirine—Abdominal pain—Sunitinib—pancreatic cancer	0.000289	0.00215	CcSEcCtD
Rilpivirine—Diarrhoea—Erlotinib—pancreatic cancer	0.000289	0.00215	CcSEcCtD
Rilpivirine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000288	0.00214	CcSEcCtD
Rilpivirine—Urethral disorder—Docetaxel—pancreatic cancer	0.000288	0.00213	CcSEcCtD
Rilpivirine—Infection—Fluorouracil—pancreatic cancer	0.000287	0.00213	CcSEcCtD
Rilpivirine—Skin disorder—Gemcitabine—pancreatic cancer	0.000285	0.00212	CcSEcCtD
Rilpivirine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000283	0.0021	CcSEcCtD
Rilpivirine—Dizziness—Tamoxifen—pancreatic cancer	0.000283	0.0021	CcSEcCtD
Rilpivirine—Dizziness—Erlotinib—pancreatic cancer	0.00028	0.00208	CcSEcCtD
Rilpivirine—Renal impairment—Doxorubicin—pancreatic cancer	0.000278	0.00206	CcSEcCtD
Rilpivirine—Insomnia—Irinotecan—pancreatic cancer	0.000273	0.00202	CcSEcCtD
Rilpivirine—Vomiting—Tamoxifen—pancreatic cancer	0.000272	0.00202	CcSEcCtD
Rilpivirine—Rash—Tamoxifen—pancreatic cancer	0.000269	0.002	CcSEcCtD
Rilpivirine—Dermatitis—Tamoxifen—pancreatic cancer	0.000269	0.002	CcSEcCtD
Rilpivirine—Vomiting—Erlotinib—pancreatic cancer	0.000269	0.002	CcSEcCtD
Rilpivirine—Somnolence—Irinotecan—pancreatic cancer	0.000268	0.00199	CcSEcCtD
Rilpivirine—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000268	0.00199	CcSEcCtD
Rilpivirine—Headache—Tamoxifen—pancreatic cancer	0.000268	0.00199	CcSEcCtD
Rilpivirine—Rash—Erlotinib—pancreatic cancer	0.000267	0.00198	CcSEcCtD
Rilpivirine—Dermatitis—Erlotinib—pancreatic cancer	0.000266	0.00198	CcSEcCtD
Rilpivirine—Insomnia—Gemcitabine—pancreatic cancer	0.000266	0.00197	CcSEcCtD
Rilpivirine—Immune system disorder—Docetaxel—pancreatic cancer	0.000265	0.00197	CcSEcCtD
Rilpivirine—Headache—Erlotinib—pancreatic cancer	0.000265	0.00197	CcSEcCtD
Rilpivirine—Asthenia—Sunitinib—pancreatic cancer	0.000263	0.00195	CcSEcCtD
Rilpivirine—Decreased appetite—Irinotecan—pancreatic cancer	0.000262	0.00195	CcSEcCtD
Rilpivirine—Insomnia—Fluorouracil—pancreatic cancer	0.000261	0.00194	CcSEcCtD
Rilpivirine—Somnolence—Gemcitabine—pancreatic cancer	0.000261	0.00194	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00026	0.00193	CcSEcCtD
Rilpivirine—Fatigue—Irinotecan—pancreatic cancer	0.00026	0.00193	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000258	0.00191	CcSEcCtD
Rilpivirine—Mental disorder—Docetaxel—pancreatic cancer	0.000257	0.00191	CcSEcCtD
Rilpivirine—Somnolence—Fluorouracil—pancreatic cancer	0.000257	0.00191	CcSEcCtD
Rilpivirine—Malnutrition—Docetaxel—pancreatic cancer	0.000255	0.0019	CcSEcCtD
Rilpivirine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000255	0.0019	CcSEcCtD
Rilpivirine—Nausea—Tamoxifen—pancreatic cancer	0.000254	0.00188	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000254	0.00188	CcSEcCtD
Rilpivirine—Fatigue—Gemcitabine—pancreatic cancer	0.000253	0.00188	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000252	0.00187	CcSEcCtD
Rilpivirine—Nausea—Erlotinib—pancreatic cancer	0.000251	0.00186	CcSEcCtD
Rilpivirine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000251	0.00186	CcSEcCtD
Rilpivirine—Diarrhoea—Sunitinib—pancreatic cancer	0.00025	0.00186	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000249	0.00185	CcSEcCtD
Rilpivirine—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000248	0.00184	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000247	0.00183	CcSEcCtD
Rilpivirine—Dizziness—Sunitinib—pancreatic cancer	0.000242	0.0018	CcSEcCtD
Rilpivirine—Abdominal pain—Irinotecan—pancreatic cancer	0.000238	0.00177	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000238	0.00177	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000233	0.00173	CcSEcCtD
Rilpivirine—Vomiting—Sunitinib—pancreatic cancer	0.000233	0.00173	CcSEcCtD
Rilpivirine—Rash—Sunitinib—pancreatic cancer	0.000231	0.00171	CcSEcCtD
Rilpivirine—Dermatitis—Sunitinib—pancreatic cancer	0.000231	0.00171	CcSEcCtD
Rilpivirine—Headache—Sunitinib—pancreatic cancer	0.000229	0.0017	CcSEcCtD
Rilpivirine—Nausea—Sunitinib—pancreatic cancer	0.000217	0.00161	CcSEcCtD
Rilpivirine—Renal failure—Epirubicin—pancreatic cancer	0.000217	0.00161	CcSEcCtD
Rilpivirine—Asthenia—Irinotecan—pancreatic cancer	0.000216	0.00161	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000216	0.0016	CcSEcCtD
Rilpivirine—Dry mouth—Docetaxel—pancreatic cancer	0.000213	0.00158	CcSEcCtD
Rilpivirine—Asthenia—Gemcitabine—pancreatic cancer	0.000211	0.00156	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000208	0.00155	CcSEcCtD
Rilpivirine—Infection—Docetaxel—pancreatic cancer	0.000207	0.00154	CcSEcCtD
Rilpivirine—Diarrhoea—Irinotecan—pancreatic cancer	0.000206	0.00153	CcSEcCtD
Rilpivirine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000204	0.00152	CcSEcCtD
Rilpivirine—Skin disorder—Docetaxel—pancreatic cancer	0.000202	0.0015	CcSEcCtD
Rilpivirine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000201	0.00149	CcSEcCtD
Rilpivirine—Renal failure—Doxorubicin—pancreatic cancer	0.0002	0.00149	CcSEcCtD
Rilpivirine—Dizziness—Irinotecan—pancreatic cancer	0.000199	0.00148	CcSEcCtD
Rilpivirine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000198	0.00147	CcSEcCtD
Rilpivirine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000195	0.00145	CcSEcCtD
Rilpivirine—Urethral disorder—Epirubicin—pancreatic cancer	0.000194	0.00144	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000193	0.00143	CcSEcCtD
Rilpivirine—Vomiting—Irinotecan—pancreatic cancer	0.000192	0.00142	CcSEcCtD
Rilpivirine—Dizziness—Fluorouracil—pancreatic cancer	0.000191	0.00142	CcSEcCtD
Rilpivirine—Rash—Irinotecan—pancreatic cancer	0.00019	0.00141	CcSEcCtD
Rilpivirine—Dermatitis—Irinotecan—pancreatic cancer	0.00019	0.00141	CcSEcCtD
Rilpivirine—Headache—Irinotecan—pancreatic cancer	0.000189	0.0014	CcSEcCtD
Rilpivirine—Insomnia—Docetaxel—pancreatic cancer	0.000188	0.0014	CcSEcCtD
Rilpivirine—Vomiting—Gemcitabine—pancreatic cancer	0.000187	0.00139	CcSEcCtD
Rilpivirine—Somnolence—Docetaxel—pancreatic cancer	0.000185	0.00138	CcSEcCtD
Rilpivirine—Rash—Gemcitabine—pancreatic cancer	0.000185	0.00137	CcSEcCtD
Rilpivirine—Dermatitis—Gemcitabine—pancreatic cancer	0.000185	0.00137	CcSEcCtD
Rilpivirine—Headache—Gemcitabine—pancreatic cancer	0.000184	0.00137	CcSEcCtD
Rilpivirine—Vomiting—Fluorouracil—pancreatic cancer	0.000184	0.00136	CcSEcCtD
Rilpivirine—Rash—Fluorouracil—pancreatic cancer	0.000182	0.00135	CcSEcCtD
Rilpivirine—Dermatitis—Fluorouracil—pancreatic cancer	0.000182	0.00135	CcSEcCtD
Rilpivirine—Decreased appetite—Docetaxel—pancreatic cancer	0.000181	0.00134	CcSEcCtD
Rilpivirine—Headache—Fluorouracil—pancreatic cancer	0.000181	0.00134	CcSEcCtD
Rilpivirine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000181	0.00134	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00018	0.00134	CcSEcCtD
Rilpivirine—Fatigue—Docetaxel—pancreatic cancer	0.00018	0.00133	CcSEcCtD
Rilpivirine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000179	0.00133	CcSEcCtD
Rilpivirine—Nausea—Irinotecan—pancreatic cancer	0.000179	0.00133	CcSEcCtD
Rilpivirine—Immune system disorder—Epirubicin—pancreatic cancer	0.000179	0.00133	CcSEcCtD
Rilpivirine—Nausea—Gemcitabine—pancreatic cancer	0.000174	0.00129	CcSEcCtD
Rilpivirine—Mental disorder—Epirubicin—pancreatic cancer	0.000173	0.00129	CcSEcCtD
Rilpivirine—Malnutrition—Epirubicin—pancreatic cancer	0.000172	0.00128	CcSEcCtD
Rilpivirine—Nausea—Fluorouracil—pancreatic cancer	0.000172	0.00127	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00017	0.00127	CcSEcCtD
Rilpivirine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000165	0.00123	CcSEcCtD
Rilpivirine—Abdominal pain—Docetaxel—pancreatic cancer	0.000165	0.00122	CcSEcCtD
Rilpivirine—Mental disorder—Doxorubicin—pancreatic cancer	0.00016	0.00119	CcSEcCtD
Rilpivirine—Malnutrition—Doxorubicin—pancreatic cancer	0.000159	0.00118	CcSEcCtD
Rilpivirine—Asthenia—Docetaxel—pancreatic cancer	0.00015	0.00111	CcSEcCtD
Rilpivirine—Anxiety—Epirubicin—pancreatic cancer	0.000146	0.00108	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000146	0.00108	CcSEcCtD
Rilpivirine—Dry mouth—Epirubicin—pancreatic cancer	0.000143	0.00106	CcSEcCtD
Rilpivirine—Diarrhoea—Docetaxel—pancreatic cancer	0.000143	0.00106	CcSEcCtD
Rilpivirine—Infection—Epirubicin—pancreatic cancer	0.00014	0.00104	CcSEcCtD
Rilpivirine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000138	0.00102	CcSEcCtD
Rilpivirine—Dizziness—Docetaxel—pancreatic cancer	0.000138	0.00102	CcSEcCtD
Rilpivirine—Skin disorder—Epirubicin—pancreatic cancer	0.000137	0.00101	CcSEcCtD
Rilpivirine—Anxiety—Doxorubicin—pancreatic cancer	0.000135	0.001	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000135	0.001	CcSEcCtD
Rilpivirine—Dry mouth—Doxorubicin—pancreatic cancer	0.000133	0.000985	CcSEcCtD
Rilpivirine—Vomiting—Docetaxel—pancreatic cancer	0.000133	0.000984	CcSEcCtD
Rilpivirine—Rash—Docetaxel—pancreatic cancer	0.000131	0.000975	CcSEcCtD
Rilpivirine—Dermatitis—Docetaxel—pancreatic cancer	0.000131	0.000975	CcSEcCtD
Rilpivirine—Headache—Docetaxel—pancreatic cancer	0.000131	0.000969	CcSEcCtD
Rilpivirine—Infection—Doxorubicin—pancreatic cancer	0.000129	0.000959	CcSEcCtD
Rilpivirine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000128	0.000947	CcSEcCtD
Rilpivirine—Insomnia—Epirubicin—pancreatic cancer	0.000127	0.000944	CcSEcCtD
Rilpivirine—Skin disorder—Doxorubicin—pancreatic cancer	0.000126	0.000938	CcSEcCtD
Rilpivirine—Somnolence—Epirubicin—pancreatic cancer	0.000125	0.000928	CcSEcCtD
Rilpivirine—Nausea—Docetaxel—pancreatic cancer	0.000124	0.000919	CcSEcCtD
Rilpivirine—Decreased appetite—Epirubicin—pancreatic cancer	0.000122	0.000907	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000121	0.000901	CcSEcCtD
Rilpivirine—Fatigue—Epirubicin—pancreatic cancer	0.000121	0.0009	CcSEcCtD
Rilpivirine—Insomnia—Doxorubicin—pancreatic cancer	0.000118	0.000873	CcSEcCtD
Rilpivirine—Somnolence—Doxorubicin—pancreatic cancer	0.000116	0.000858	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000115	0.000853	CcSEcCtD
Rilpivirine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000113	0.000839	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000112	0.000834	CcSEcCtD
Rilpivirine—Fatigue—Doxorubicin—pancreatic cancer	0.000112	0.000832	CcSEcCtD
Rilpivirine—Abdominal pain—Epirubicin—pancreatic cancer	0.000111	0.000825	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000106	0.00079	CcSEcCtD
Rilpivirine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000103	0.000763	CcSEcCtD
Rilpivirine—Asthenia—Epirubicin—pancreatic cancer	0.000101	0.000749	CcSEcCtD
Rilpivirine—Diarrhoea—Epirubicin—pancreatic cancer	9.62e-05	0.000714	CcSEcCtD
Rilpivirine—Asthenia—Doxorubicin—pancreatic cancer	9.33e-05	0.000693	CcSEcCtD
Rilpivirine—Dizziness—Epirubicin—pancreatic cancer	9.3e-05	0.00069	CcSEcCtD
Rilpivirine—Vomiting—Epirubicin—pancreatic cancer	8.94e-05	0.000663	CcSEcCtD
Rilpivirine—Diarrhoea—Doxorubicin—pancreatic cancer	8.9e-05	0.000661	CcSEcCtD
Rilpivirine—Rash—Epirubicin—pancreatic cancer	8.86e-05	0.000658	CcSEcCtD
Rilpivirine—Dermatitis—Epirubicin—pancreatic cancer	8.85e-05	0.000657	CcSEcCtD
Rilpivirine—Headache—Epirubicin—pancreatic cancer	8.81e-05	0.000654	CcSEcCtD
Rilpivirine—Dizziness—Doxorubicin—pancreatic cancer	8.6e-05	0.000638	CcSEcCtD
Rilpivirine—Nausea—Epirubicin—pancreatic cancer	8.35e-05	0.00062	CcSEcCtD
Rilpivirine—Vomiting—Doxorubicin—pancreatic cancer	8.27e-05	0.000614	CcSEcCtD
Rilpivirine—Rash—Doxorubicin—pancreatic cancer	8.2e-05	0.000609	CcSEcCtD
Rilpivirine—Dermatitis—Doxorubicin—pancreatic cancer	8.19e-05	0.000608	CcSEcCtD
Rilpivirine—Headache—Doxorubicin—pancreatic cancer	8.15e-05	0.000605	CcSEcCtD
Rilpivirine—Nausea—Doxorubicin—pancreatic cancer	7.73e-05	0.000573	CcSEcCtD
Rilpivirine—NR1I2—Generic Transcription Pathway—PPARG—pancreatic cancer	8.56e-06	0.00302	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	8.15e-06	0.00287	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—EZH2—pancreatic cancer	8.04e-06	0.00283	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	7.99e-06	0.00282	CbGpPWpGaD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	7.93e-06	0.0028	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—NOTCH3—pancreatic cancer	7.87e-06	0.00277	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	7.72e-06	0.00272	CbGpPWpGaD
Rilpivirine—CYP2C19—Arachidonic acid metabolism—PTGS2—pancreatic cancer	7.62e-06	0.00269	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—HSPA1A—pancreatic cancer	7.45e-06	0.00263	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PRSS1—pancreatic cancer	7.37e-06	0.0026	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	7.31e-06	0.00258	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	7.22e-06	0.00254	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ARG2—pancreatic cancer	6.39e-06	0.00225	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	6.35e-06	0.00224	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	6.31e-06	0.00222	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	6.2e-06	0.00219	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.03e-06	0.00213	CbGpPWpGaD
Rilpivirine—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	5.94e-06	0.00209	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—SMAD4—pancreatic cancer	5.92e-06	0.00209	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—TYMP—pancreatic cancer	5.59e-06	0.00197	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.59e-06	0.00197	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	5.54e-06	0.00195	CbGpPWpGaD
Rilpivirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	5.48e-06	0.00193	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	5.31e-06	0.00187	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	5.13e-06	0.00181	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	5.13e-06	0.00181	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	5e-06	0.00176	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	5e-06	0.00176	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PRSS1—pancreatic cancer	4.95e-06	0.00175	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	4.94e-06	0.00174	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—MYC—pancreatic cancer	4.88e-06	0.00172	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	4.8e-06	0.00169	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	4.79e-06	0.00169	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	4.69e-06	0.00165	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	4.65e-06	0.00164	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.61e-06	0.00163	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	4.6e-06	0.00162	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	4.59e-06	0.00162	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PRSS1—pancreatic cancer	4.59e-06	0.00162	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	4.57e-06	0.00161	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GLP1R—pancreatic cancer	4.5e-06	0.00159	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	4.5e-06	0.00159	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	4.5e-06	0.00159	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—DPYD—pancreatic cancer	4.43e-06	0.00156	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—NOTCH1—pancreatic cancer	4.37e-06	0.00154	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ARG2—pancreatic cancer	4.3e-06	0.00151	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	4.28e-06	0.00151	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	4.28e-06	0.00151	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	4.25e-06	0.0015	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—SLC2A2—pancreatic cancer	4.21e-06	0.00148	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.16e-06	0.00147	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—PPARG—pancreatic cancer	4.12e-06	0.00145	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	4.06e-06	0.00143	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.02e-06	0.00142	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ARG2—pancreatic cancer	3.98e-06	0.0014	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—TYMP—pancreatic cancer	3.75e-06	0.00132	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	3.73e-06	0.00131	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.66e-06	0.00129	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	3.61e-06	0.00127	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—TNF—pancreatic cancer	3.48e-06	0.00123	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—TYMP—pancreatic cancer	3.48e-06	0.00123	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	3.46e-06	0.00122	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PRSS1—pancreatic cancer	3.36e-06	0.00119	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.31e-06	0.00117	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CD44—pancreatic cancer	3.26e-06	0.00115	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.19e-06	0.00112	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.16e-06	0.00111	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GCG—pancreatic cancer	3.12e-06	0.0011	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.1e-06	0.00109	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GLP1R—pancreatic cancer	3.03e-06	0.00107	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.02e-06	0.00106	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	2.99e-06	0.00106	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—DPYD—pancreatic cancer	2.98e-06	0.00105	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—STK11—pancreatic cancer	2.94e-06	0.00104	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ARG2—pancreatic cancer	2.92e-06	0.00103	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—SLC2A2—pancreatic cancer	2.83e-06	0.000996	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GLP1R—pancreatic cancer	2.8e-06	0.000988	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.8e-06	0.000986	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—DPYD—pancreatic cancer	2.76e-06	0.000972	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.76e-06	0.000972	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.7e-06	0.000952	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—SLC2A2—pancreatic cancer	2.62e-06	0.000922	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—TYMP—pancreatic cancer	2.55e-06	0.000899	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.54e-06	0.000897	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PRSS1—pancreatic cancer	2.54e-06	0.000896	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—TYMS—pancreatic cancer	2.53e-06	0.00089	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PRSS1—pancreatic cancer	2.48e-06	0.000875	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.46e-06	0.000867	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.36e-06	0.000833	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—MYC—pancreatic cancer	2.35e-06	0.000829	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.3e-06	0.000811	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.28e-06	0.000803	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.22e-06	0.000783	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ARG2—pancreatic cancer	2.2e-06	0.000777	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CD44—pancreatic cancer	2.19e-06	0.000772	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ARG2—pancreatic cancer	2.15e-06	0.000758	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.14e-06	0.000755	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.12e-06	0.000749	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GCG—pancreatic cancer	2.1e-06	0.00074	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.06e-06	0.000726	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GLP1R—pancreatic cancer	2.05e-06	0.000724	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—APOE—pancreatic cancer	2.05e-06	0.000724	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CD44—pancreatic cancer	2.03e-06	0.000714	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—DPYD—pancreatic cancer	2.02e-06	0.000713	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2e-06	0.000707	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.98e-06	0.000698	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—STK11—pancreatic cancer	1.97e-06	0.000695	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.94e-06	0.000685	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GCG—pancreatic cancer	1.94e-06	0.000685	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.93e-06	0.000679	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—SLC2A2—pancreatic cancer	1.92e-06	0.000676	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—TYMP—pancreatic cancer	1.88e-06	0.000663	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CG—pancreatic cancer	1.85e-06	0.000654	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.85e-06	0.000653	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.84e-06	0.00065	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.84e-06	0.000649	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—STK11—pancreatic cancer	1.83e-06	0.000644	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.8e-06	0.000636	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PPARG—pancreatic cancer	1.79e-06	0.000631	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.72e-06	0.000606	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.72e-06	0.000605	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.7e-06	0.000601	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—TYMS—pancreatic cancer	1.7e-06	0.000598	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—AKT1—pancreatic cancer	1.63e-06	0.000575	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CD—pancreatic cancer	1.63e-06	0.000575	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.59e-06	0.00056	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—TYMS—pancreatic cancer	1.57e-06	0.000554	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.57e-06	0.000552	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.55e-06	0.000547	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.53e-06	0.000539	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.53e-06	0.000538	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.52e-06	0.000534	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.51e-06	0.000534	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.5e-06	0.000529	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—DPYD—pancreatic cancer	1.49e-06	0.000526	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CD44—pancreatic cancer	1.49e-06	0.000524	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.45e-06	0.000511	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.43e-06	0.000506	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GCG—pancreatic cancer	1.42e-06	0.000502	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CB—pancreatic cancer	1.42e-06	0.000501	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.41e-06	0.000499	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTGS2—pancreatic cancer	1.41e-06	0.000496	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.38e-06	0.000488	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—APOE—pancreatic cancer	1.38e-06	0.000487	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—STK11—pancreatic cancer	1.34e-06	0.000472	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.32e-06	0.000467	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.31e-06	0.000461	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.28e-06	0.000451	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—APOE—pancreatic cancer	1.28e-06	0.00045	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.26e-06	0.000445	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	1.25e-06	0.000439	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.24e-06	0.000437	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTEN—pancreatic cancer	1.23e-06	0.000433	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GLP1R—pancreatic cancer	1.21e-06	0.000426	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PPARG—pancreatic cancer	1.2e-06	0.000424	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—DPYD—pancreatic cancer	1.19e-06	0.00042	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.16e-06	0.000408	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CG—pancreatic cancer	1.15e-06	0.000407	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—TYMS—pancreatic cancer	1.15e-06	0.000406	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	1.13e-06	0.000398	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CD44—pancreatic cancer	1.12e-06	0.000396	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.12e-06	0.000394	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PPARG—pancreatic cancer	1.11e-06	0.000392	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.1e-06	0.000387	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CD44—pancreatic cancer	1.1e-06	0.000386	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	1.09e-06	0.000386	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.09e-06	0.000384	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.08e-06	0.00038	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GCG—pancreatic cancer	1.08e-06	0.000379	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GCG—pancreatic cancer	1.05e-06	0.00037	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CD—pancreatic cancer	1.01e-06	0.000357	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—STK11—pancreatic cancer	1.01e-06	0.000357	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—STK11—pancreatic cancer	9.87e-07	0.000348	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.82e-07	0.000346	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	9.54e-07	0.000336	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.5e-07	0.000335	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	9.45e-07	0.000333	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—APOE—pancreatic cancer	9.37e-07	0.00033	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	9.33e-07	0.000329	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—DPYD—pancreatic cancer	9.18e-07	0.000324	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CB—pancreatic cancer	8.83e-07	0.000312	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTGS2—pancreatic cancer	8.75e-07	0.000309	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CD44—pancreatic cancer	8.74e-07	0.000308	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	8.71e-07	0.000307	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—TYMS—pancreatic cancer	8.7e-07	0.000307	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CA—pancreatic cancer	8.66e-07	0.000305	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.56e-07	0.000302	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—TYMS—pancreatic cancer	8.49e-07	0.000299	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.48e-07	0.000299	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	8.45e-07	0.000298	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GCG—pancreatic cancer	8.38e-07	0.000296	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTEN—pancreatic cancer	8.24e-07	0.000291	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PPARG—pancreatic cancer	8.16e-07	0.000288	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—STK11—pancreatic cancer	7.88e-07	0.000278	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTEN—pancreatic cancer	7.63e-07	0.000269	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	7.43e-07	0.000262	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.4e-07	0.000261	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APOE—pancreatic cancer	7.08e-07	0.00025	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—AKT1—pancreatic cancer	7.07e-07	0.000249	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APOE—pancreatic cancer	6.91e-07	0.000244	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—TYMS—pancreatic cancer	6.78e-07	0.000239	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CD44—pancreatic cancer	6.75e-07	0.000238	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.7e-07	0.000236	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	6.48e-07	0.000228	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GCG—pancreatic cancer	6.47e-07	0.000228	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTGS2—pancreatic cancer	6.42e-07	0.000226	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	6.39e-07	0.000225	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	6.23e-07	0.00022	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPARG—pancreatic cancer	6.16e-07	0.000217	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—STK11—pancreatic cancer	6.08e-07	0.000214	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPARG—pancreatic cancer	6.02e-07	0.000212	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	5.82e-07	0.000205	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	5.61e-07	0.000198	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTEN—pancreatic cancer	5.6e-07	0.000197	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOE—pancreatic cancer	5.51e-07	0.000194	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	5.48e-07	0.000193	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CA—pancreatic cancer	5.39e-07	0.00019	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.23e-07	0.000185	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.22e-07	0.000184	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	4.98e-07	0.000175	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	4.89e-07	0.000173	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	4.85e-07	0.000171	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPARG—pancreatic cancer	4.8e-07	0.000169	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	4.78e-07	0.000168	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—AKT1—pancreatic cancer	4.75e-07	0.000168	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTGS2—pancreatic cancer	4.73e-07	0.000167	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—AKT1—pancreatic cancer	4.4e-07	0.000155	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	4.37e-07	0.000154	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOE—pancreatic cancer	4.26e-07	0.00015	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTEN—pancreatic cancer	4.23e-07	0.000149	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTEN—pancreatic cancer	4.13e-07	0.000146	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	3.95e-07	0.000139	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.84e-07	0.000135	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	3.81e-07	0.000134	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	3.78e-07	0.000133	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.71e-07	0.000131	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.38e-07	0.000119	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTEN—pancreatic cancer	3.3e-07	0.000116	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—AKT1—pancreatic cancer	3.23e-07	0.000114	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2.98e-07	0.000105	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.94e-07	0.000104	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.92e-07	0.000103	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.91e-07	0.000103	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.54e-07	8.97e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—AKT1—pancreatic cancer	2.44e-07	8.59e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—AKT1—pancreatic cancer	2.38e-07	8.39e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.32e-07	8.2e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.9e-07	6.7e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.79e-07	6.33e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.47e-07	5.17e-05	CbGpPWpGaD
